Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

FDA Panel Gives Thumbs Up To DuraSeal Xact Spine Surgery Sealant

This article was originally published in The Gray Sheet

Executive Summary

Covidien's DuraSeal Xact dural repair sealant for spine surgery should be approved with conditions, FDA's Neurological Devices panel recommended in a unanimous 4-0 vote May 14
Advertisement

Related Content

Lurie Joins FDA: Critic Of Agency, Industry Will Help Make Regulatory Policy
Lurie Joins FDA: Critic Of Agency, Industry Will Help Make Regulatory Policy
Covidien's Spine Surgery Sealant To Launch In U.S. Next Month
Covidien's Spine Surgery Sealant To Launch In U.S. Next Month
FDA Neuro Panel Will Review Cyberonics, Confluent Postmarket Data
FDA Neuro Panel Will Review Cyberonics, Confluent Postmarket Data

Topics

Advertisement
UsernamePublicRestriction

Register

MT027445

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel